株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

デジタルパソロジーに関する考察:各種イメージング技術・専門家による展望・標準化・現在の見通し

Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization and Current Outlooks

発行 Insight Pharma Reports 商品コード 298558
出版日 ページ情報 英文 145 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.66円で換算しております。
Back to Top
デジタルパソロジーに関する考察:各種イメージング技術・専門家による展望・標準化・現在の見通し Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization and Current Outlooks
出版日: 2015年10月31日 ページ情報: 英文 145 Pages
概要

当レポートでは、デジタルパソロジー技術の発展動向について調査分析し、デジタルパソロジーの技術概要、現在の応用分野と今後の展望、技術導入の推進要素と障壁、法規制環境、標準化の動向、主要企業と保有技術、エンドユーザーおよび技術開発者による考察の調査結果などをまとめ、概略下記の構成で取り上げております。

パート1:デジタルパソロジーについて

第1章 デジタルパソロジーとは

  • 病理学におけるデジタルイメージング
  • ホールスライドイメージング
  • 遠隔病理診断(テレパソロジー)に関する注釈

第2章 現在の用途と新しい用途

  • 現在の用途
    • 教育
    • コンサルテーション・セカンドオピニオン
    • 凍結切片の画像解釈
    • 品質保証
    • 画像解析
  • 新しい用途
    • マルチスペクトル画像
    • 一次診断にためのWSI
    • コンピュータ支援診断

第3章 市場の展望

  • デジタルパソロジーの導入の推進要素
  • 障壁
  • 予測

第4章 法規制・規格標準の発展

  • International Color Consortium (ICC)
  • Digital Imaging and Communications in Medicine (DICOM) 規格委員会
  • U.S. Food and Drug Administration (FDA)
  • Clinical Laboratory Improvement Amendments (CLIA)
  • College of American Pathologists (CAP)
  • Craig Revie氏へのインタビュー

パート2:デジタルイメージング技術:顕微鏡撮像システム

第5章 Applied Spectral Imaging

  • 企業背景
  • 技術
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • Limor Shiposh氏へのインタビュー

第6章 Nikon Instruments Inc.

  • 企業背景
  • 技術
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • Stanley Schwartz氏へのインタビュー

パート3 デジタルイメージング技術:ホールスライドスキャナー

第7章 3DHISTECH Ltd.

  • 企業背景
  • 技術
  • P250 FLASH II Scanner
  • Pannoramic Confocal Scanner
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • Viktor Varga博士へのインタビュー

第8章 Carl Zeiss Microscopy GmbH

  • 企業背景
  • 技術
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • Thorsten Heupel博士へのインタビュー

第9章 DigiPath Corp.

  • 企業背景
  • 技術
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • Steve Barbee氏へのインタビュー

第10章 FFEI Ltd.

  • 企業背景
  • 技術
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • George Hutchinson氏へのインタビュー

第11章 Huron Technologies

  • 企業背景
  • 技術
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • Reda Fayek氏へのインタビュー

第12章 Philips Digital Pathology Solutions

  • 企業背景
  • 技術
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • Perry van Rijsingen氏へのインタビュー

第13章 ホールスライドスキャナー:仕様の比較

パート4 注目の革新

第14章 注目の革新:PerkinElmer

  • 企業背景
  • 技術
  • VectraR
  • LaminaR
  • 提携
  • 競争上の優位性
  • 将来の取り組み
  • デジタルパソロジーの展望:標準化と展望
  • James Mansfield氏へのインタビュー

パート5 ケーススタディー;患者ケアのためのデジタルパソロジー

THE CLEVELAND CLINICの事例

第15章

  • Thomas W. Bauer 博士へのインタビュー

パート6 調査結果:エンドユーザーおよびディベロッパーの展望

第16章 調査結果;技術の進歩

  • 課題
  • 利点
  • 技術開発者からのその他の考察
  • エンドユーザーからのその他の考察

参照

Cambridge Healthtech Instituteについて

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

New to Insight Pharma Reports is Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks. This report delves into the rapidly evolving field of digital pathology, briefly reviewing the underlying scientific and technological concepts and providing an insightful perspective on various factors thought to be of significance to the development and future of this space.

Broken into several sections, the beginning of this report provides an overview of digital pathology including:

  • Terminology and definitions
  • Types of digital imaging systems (including whole slide scanners)
  • Technical underpinnings
  • Current and emerging applications

A brief overview of the digital pathology market will cover identified drivers and obstacles as well as current forecasts. The FDA and several standards organizations are profiled with regard to activities that may impact the furtherance of this field. Included in this section is an exclusive interview with Craig Revie, Chair of the International Color Consortium's Medical Imaging Working Group and project coordinator for the development of a calibration system for digital microscopes.

Updated with all new interview with Thomas W. Bauer MD, PhD Medical Director for ePathology Medical Director, Cleveland Clinic Central Biorepository Departments of Pathology, Orthopedic Surgery and The Spine Center, Cleveland Clinic discussing Whole Slide Imaging Repository.

Companies featured in this report include:

  • 3DHISTECH
  • Applied Spectral Imaging
  • Carl Zeiss Microscopy GmbH
  • DigiPath Corp
  • FFEI Ltd.
  • Huron Technologies
  • Nikon Instruments
  • PerkinElmer
  • Philips Digital Pathology Solutions

These companies have provided valuable insights as to the evolution of digital pathology within their businesses, the details of their current imaging systems, strategies, and techniques, as well as their individual perspectives on the establishment of standards in digital pathology, the challenges the field may face and the benefits that await as a digital environment becomes commonplace in pathology. Interviews with the expert company representatives are also included.

Finally, the report concludes with a unique look at the current climate of the digital pathology space based on a survey conducted by Insight Pharma Reports which polled a group of individuals identified as end users or developers of digital pathology technologies. An in depth analysis of these results compares the perspectives of both demographics on several important topics revealing areas of commonality and also divergence. Topics include areas most in need of improvement and the challenges and benefits associated with the use and development of digital pathology technologies.

Table of Contents

Executive Summary

PART 1: AN INTRODUCTION TO DIGITAL PATHOLOGY

CHAPTER 1: What is Digital Pathology?

  • Digital Imaging in Pathology
  • Whole Slide Imaging
  • A Brief Note on Telepathology

CHAPTER 2: Current and Emerging Applications

  • Current Applications
    • Education
    • Consultations and Second Opinions
    • Frozen Section Interpretation
    • Quality Assurance
    • Image Analysis
  • Emerging Applications
    • Multispectral Imaging
    • WSI for Primary Diagnosis
    • Computer Aided Diagnosis

CHAPTER 3: Market Outlook

  • What Will Facilitate the Adoption of Digital Pathology?
  • Barriers
  • Forecasts

CHAPTER 4: Regulation and Standards Development

  • International Color Consortium (ICC)
  • Digital Imaging and Communications in Medicine (DICOM) Standards Committee
  • U.S. Food and Drug Administration (FDA)
  • Clinical Laboratory Improvement Amendments (CLIA)
  • College of American Pathologists (CAP)
  • Interview with Craig Revie

PART II: DIGITAL IMAGING TECHNOLOGIES: MICROSCOPE IMAGING SYSTEMS

CHAPTER 5: Applied Spectral Imaging

  • Company Background
  • Technologies
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with Limor Shiposh

CHAPTER 6: Nikon Instruments Inc.

  • Company Background
  • Technologies
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with Stanley Schwartz

PART III: DIGITAL IMAGING TECHNOLOGIES: WHOLE SLIDE SCANNERS

CHAPTER 7: 3DHISTECH Ltd.

  • Company Background
  • Technologies
  • P250 FLASH II Scanner
  • Pannoramic Confocal Scanner
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with Dr. Viktor Varga

CHAPTER 8: Carl Zeiss Microscopy GmbH

  • Company Background
  • Technologies
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with Dr. Thorsten Heupel

CHAPTER 9: DigiPath Corp.

  • Company Background
  • Technologies
  • Collaboration
  • Competitive Advantage
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with Steve Barbee

CHAPTER 10: FFEI Ltd.

  • Company Background
  • Technologies
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with George Hutchinson

CHAPTER 11: Huron Technologies

  • Company Background
  • Technologies
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with Réda Fayek

CHAPTER 12: Philips Digital Pathology Solutions

  • Company Background
  • Technologies
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with Perry van Rijsingen

CHAPTER 13: Whole Slide Scanners: A Comparison of Specifications

PART IV: INNOVATION SPOTLIGHT

CHAPTER 14: Innovation Spotlight: PerkinElmer

  • Company Background
  • Technologies
  • Vectra®
  • Lamina®
  • Collaboration
  • Competitive Advantage
  • Future Endeavors
  • Digital Pathology Outlook: Standardization and Perspectives
  • Interview with James Mansfield

PART V: A CASE STUDY - DIGITAL PATHOLOGY FOR PATIENT CARE: THE CLEVELAND CLINIC

CHAPTER 15

  • An Interview with Thomas W. Bauer MD, PhD The Cleveland Clinic

PART VI: SURVEY RESULTS: END USER AND DEVELOPER PERSPECTIVES

CHAPTER 16: Survey ResultsTechnological Improvement

  • Challenges
  • Benefits
  • Additional Insights from Technology Developers
  • Additional Insights from End Users

References

About Cambridge Healthtech Institute

Tables:

  • Table 5.1. Advantages of ASI's GenASIs Platforms
  • Table 5.2. ASI GenASIs Imaging Platforms Overview
  • Table 6.1. DS-Fi2 Camera Overview
  • Table 6.2. DS-L3 Standalone Control Unit Overview
  • Table 6.3. Advantages of the Nikon Digital Sight System
  • Table 7.1. 3DHISTECH Pannoramic 250 FLASH II Benefitsand Limitations
  • Table7.2. 3DHISTECH Product Overview
  • Table 8.1. ZEISS Axio Scan.Z1 Benefits and Limitations
  • Table 8.2: ZEISS Axio Scan.Z1 Overview
  • Table 9.1. Advantages of the DigiPath PathScope
  • Table 9.2. DigiPath PathScope Overview
  • Table 10.1. FFEI Ltd. Dynamo Overview
  • Table 11.1. Huron Technologies TISSUEscope™ Benefitsand Limitations
  • Table 11.2. Huron Technologies TISSUEscope™ Scanners Overview
  • Table 12.1. Philips Ultra Fast Scanner Benefits and Limitations
  • Table 12.2. Philips Ultra Fast Scanner Product Overview
  • Table 13.1. Product Comparison: Whole Slide Scanners
  • Table 14.1. Vectra® Automated Multispectral Imaging System Benefits and Limitations
  • Table 14.2. Lamina™ Multilabel Slide Scanner Benefitsand Limitations
  • Table 14.3. Lamina™ Multilabel Slide Scanner Product Overview

Figures:

  • Figure 1.1. Continued Growth of Interest in Digital Pathology
  • Figure 2.1. Continued Growth of Interest in Multispectral Imaging
  • Figure 15.1. Survey Respondent Self-Identification
  • Figure 15.2. Comparison of End User and Developer Affiliations by Organization Type
  • Figure 15.3. Areas Having the Greatest Room for Improvement According to End Users
  • Figure 15.4. Aspects of Scanners Having the Greatest Room for Improvement According to End Users
  • Figure 15.5. Areas of Analysis Having the Greatest Room for Improvement According to End Users
  • Figure 15.6. Aspects of Scanners Having the Greatest Room for Improvement According to Developers
  • Figure 15.7. Aspects of Analysis Having the Greatest Room for Improvement According to Developers
  • Figure 15.8. Challenges Encountered in Technology Development
  • Figure 15.9. Challenges Facing End Users
  • Figure 15.10. Perceived Benefits Among End Users
  • Figure 15.11. End User Perspectives on Where Digital Pathology Will Have the Greatest Impact on Healthcare
  • Figure 15.12. Developer Perspectives on the Area That Will Benefit Most from Innovations in Digital Pathology Technologies
  • Figure 15.13. Types of Technologies Being Developed
  • Figure 15.14. Status of Current Technologies
  • Figure 15.15. Collaboration Among Technology Developers with Biotechnology and Pharmaceutical Companies
  • Figure 15.16. According to Developers, "An organization will be successful. . ."
  • Figure 15.17. End User Areas of Research
  • Figure 15.18. End Users Indicate How Digital Pathology Applies to Their Work
Back to Top